Status:
RECRUITING
Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II)
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cancer
Post-cancer
Eligibility:
All Genders
18-74 years
Phase:
NA
Brief Summary
Therapeutic advances in oncology have transformed the prognosis of cancer patients, placing a significant number of them either in a context of recovery or in prolonged remission close to a chronic di...
Eligibility Criteria
Inclusion
- Age : 18 to 74 years
- localization of the primitive: breast, lung, melanoma, testicle, bladder, kidney, ovary, colon and pancreas, hemopathy
- patient who benefited from the post-cancer assessment day
Exclusion
- Active cancer (relapse or new cancer)
- Pregnant or breastfeeding women
- Major cognitive impairment making comprehension and exercise difficult
- Amputation of both lower limbs (for ultrasound)
- Difficulty understanding oral and written French
- Adults under legal protection (guardianship, curatorship or safeguard of justice)
Key Trial Info
Start Date :
February 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 10 2029
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT06007794
Start Date
February 10 2025
End Date
May 10 2029
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Lyon Sud, rhumatologie
Pierre-Bénite, France, 69495